127 related articles for article (PubMed ID: 6189458)
41. A longitudinal study on urinary cadmium and renal tubular protein excretion of nickel-cadmium battery workers after cessation of cadmium exposure.
Gao Y; Zhang Y; Yi J; Zhou J; Huang X; Shi X; Xiao S; Lin D
Int Arch Occup Environ Health; 2016 Oct; 89(7):1137-45. PubMed ID: 27376891
[TBL] [Abstract][Full Text] [Related]
42. Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration.
Moriguchi J; Ezaki T; Tsukahara T; Furuki K; Fukui Y; Okamoto S; Ukai H; Sakurai H; Shimbo S; Ikeda M
Toxicol Lett; 2003 Aug; 143(3):279-90. PubMed ID: 12849688
[TBL] [Abstract][Full Text] [Related]
43. Serial changes in urinary cadmium concentrations and degree of renal tubular injury after soil replacement in cadmium-polluted rice paddies.
Kobayashi E; Suwazono Y; Honda R; Dochi M; Nishijo M; Kido T; Nakagawa H
Toxicol Lett; 2008 Jan; 176(2):124-30. PubMed ID: 18065169
[TBL] [Abstract][Full Text] [Related]
44. Tolerable level of lifetime cadmium intake estimated as a benchmark dose low, based on excretion of beta2-microglobulin in the cadmium-polluted regions of the Kakehashi River Basin, Japan.
Kobayashi E; Suwazono Y; Uetani M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Bull Environ Contam Toxicol; 2006 Jan; 76(1):8-15. PubMed ID: 16404655
[No Abstract] [Full Text] [Related]
45. Tubular and glomerular kidney effects in the Chinese general population with low environmental cadmium exposure.
Wang D; Sun H; Wu Y; Zhou Z; Ding Z; Chen X; Xu Y
Chemosphere; 2016 Mar; 147():3-8. PubMed ID: 26751126
[TBL] [Abstract][Full Text] [Related]
46. Determination of cadmium in biological samples.
Klotz K; Weistenhöfer W; Drexler H
Met Ions Life Sci; 2013; 11():85-98. PubMed ID: 23430771
[TBL] [Abstract][Full Text] [Related]
47. Determination of urinary beta 2-microglobulin in the urine of the cadmium-poisoned rabbit.
Ogata M; Mizugaki J; Nomiyama K; Yotoriyama M; Nomiyama H; Kimura M
Ind Health; 1981; 19(2):93-8. PubMed ID: 6167539
[No Abstract] [Full Text] [Related]
48. Clinical significance of beta 2 microglobulin determination.
Revillard JP; Vincent C
Acta Clin Belg; 1980; 35 Suppl 10():14-20. PubMed ID: 6157286
[No Abstract] [Full Text] [Related]
49. Serum and urinary beta-2-microglobulin among cadmium-exposed workers.
Iwao S; Tsuchiya K; Sakurai H
J Occup Med; 1980 Jun; 22(6):399-402. PubMed ID: 6154789
[TBL] [Abstract][Full Text] [Related]
50. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas.
Moriguchi J; Inoue Y; Kamiyama S; Horiguchi M; Murata K; Sakuragi S; Fukui Y; Ohashi F; Ikeda M
Toxicol Lett; 2009 Oct; 190(1):1-8. PubMed ID: 19467302
[TBL] [Abstract][Full Text] [Related]
51. Beta 2-microglobulin and other proteins as parameter for tubular function.
Weise M; Prüfer D; Jaques G; Keller M; Mondorf AW
Contrib Nephrol; 1981; 24():88-98. PubMed ID: 6164517
[TBL] [Abstract][Full Text] [Related]
52. [Comparison of 2 indices of proximal tubular function. Malate dehydrogenase and beta-2-microglobulin].
Amodio P; Frigo A; Dal Follo M; Caregaro L; Milani L; Gatta A
Minerva Nefrol; 1980; 27(4):585-8. PubMed ID: 6166905
[No Abstract] [Full Text] [Related]
53. Urinary excretion of beta 2-microglobulin in myeloma patients.
Engström W; Hyldahl L; Wahrgren P
Clin Chim Acta; 1980 Dec; 108(3):369-74. PubMed ID: 6162592
[TBL] [Abstract][Full Text] [Related]
54. Beta 2-glycoprotein-1 (apolipoprotein H) excretion in chronic renal tubular disorders: comparison with other protein markers of tubular malfunction.
Lapsley M; Sansom PA; Marlow CT; Flynn FV; Norden AG
J Clin Pathol; 1991 Oct; 44(10):812-6. PubMed ID: 1720435
[TBL] [Abstract][Full Text] [Related]
55. Significance of elevated urinary human intestinal alkaline phosphatase in Japanese people exposed to environmental cadmium.
Kido T; Kobayashi E; Hayano M; Nogawa K; Tsuritani I; Nishijo M; Tabata M; Nakagawa H; Nuyts GD; De Broe ME
Toxicol Lett; 1995 Oct; 80(1-3):49-54. PubMed ID: 7482591
[TBL] [Abstract][Full Text] [Related]
56. [Clinical significance of serum and urinary beta2-microgobulin in renal diseases (author's transl)].
Tasugi M; Hirota T; Hasegawa O; Kimura K; Sakamoto S; Tominaga K; Ibayashi H
Nihon Jinzo Gakkai Shi; 1978 Oct; 20(10):1107-18. PubMed ID: 83417
[No Abstract] [Full Text] [Related]
57. Urinary beta 2 microglobulin in the biological monitoring of cadmium workers.
Stewart M; Hughes EG
Br J Ind Med; 1981 May; 38(2):170-4. PubMed ID: 6165378
[TBL] [Abstract][Full Text] [Related]
58. Low-level cadmium exposure in Toyama City and its surroundings in Toyama prefecture, Japan, with references to possible contribution of shellfish intake to increase urinary cadmium levels.
Yamagami T; Ezaki T; Moriguchi J; Fukui Y; Okamoto S; Ukai H; Sakurai H; Aoshima K; Ikeda M
Sci Total Environ; 2006 Jun; 362(1-3):56-67. PubMed ID: 16169058
[TBL] [Abstract][Full Text] [Related]
59. [Analysis of clinical features of mild chronic cadmium poisoning induced by different causes].
Zhang XH; Xiao XB; Li Y; Li L; Luo GM; Huang L
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Oct; 31(10):763-5. PubMed ID: 24148955
[TBL] [Abstract][Full Text] [Related]
60. [Beta-2-microglobulin. Today's knowledge and diagnostic possibilities].
Uthmann U; Geisen HP
Dtsch Med Wochenschr; 1981 Jun; 106(24):782-6. PubMed ID: 6165538
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
